What is Bicara Therapeutics's EBIT?

Bicara Therapeutics (BCAX) reported EBIT of -$60.24M in Q1 2026.

How has Bicara Therapeutics's EBIT changed year-over-year?

Bicara Therapeutics's EBIT decreased by 44.2% year-over-year, from -$41.79M to -$60.24M.

Earnings before interest and taxes — the profit from the business before financing cost and tax. Uses reported operating income where a company reports it; otherwise pre-tax income plus interest expense. Lets companies be compared on earning power independent of capital structure.

Bicara Therapeutics BCAX EBIT

EBIT at other companies

ArriVent BioPharma, Inc.AVBP

-$46.11M+30.9%

ImmunomeIMNM

-$59.33M-32.9%

Arcus BiosciencesRCUS

-$134M-9.8%

Syndax PharmaceuticalsSNDX

-$34.2M+59.2%

Eli LillyLLY

——

AmgenAMGN

——

Other financials

Income statement

See full

Operating income-$60.2M-44.2%

Net income-$56.2M-52.6%

EPS (diluted)-$0.93-36.8%

Balance sheet

See full

Cash & equivalents$323.5M-30.0%

Total debt$1.4M+144%

Total equity$514.0M+12.0%

Total assets$553.6M+15.8%

Cash flow

See full

Operating cash flow-$37.5M-33.5%

CapEx$60.0K—

Free cash flow-$37.6M-33.7%

Valuation

See full

Market cap$1.64B+81.4%

Enterprise value$1.32B+288%

Returns & leverage

See full

Return on equity-32.3%—

Debt / equity0×0.0×

Current ratio13.9×-10.8×

Where this comes from

Calculated from Bicara Therapeutics’s reported figures.

−$60.2Moperating income−$56.2Mincome before tax=-$60.24M

Plus components not separately reported this period.

The official record: Bicara Therapeutics’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →

Ask your AI about Bicara Therapeutics's ebit.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Bicara Therapeutics's EBIT?: Bicara Therapeutics (BCAX) reported EBIT of -$60.24M in Q1 2026.
How has Bicara Therapeutics's EBIT changed year-over-year?: Bicara Therapeutics's EBIT decreased by 44.2% year-over-year, from -$41.79M to -$60.24M.
What does EBIT mean?: Earnings before interest and taxes — the profit from the business before financing cost and tax. Uses reported operating income where a company reports it; otherwise pre-tax income plus interest expense. Lets companies be compared on earning power independent of capital structure.